Overview
We are committed to the creation of sustainable value for shareholders, partners and the scientific community, while adhering to the highest standards of governance and transparency.
Vision and Values
Reliability
Ulisse Biomed is based on a product excellence philosophy, which is the foundation of its customer-centric strategy. Hyris solutions and services are the means to deliver significant benefits to all clients and partners.
Innovation
Ulisse Biomed constantly explores new fields of applications and new solutions that incorporate all the elements needed to deploy a top-rating network of biosensing units: anywhere, anytime.
Care
Ulisse Biomed always put the user at the center of its solutions, as taking care of life begins with the capability to assess in time the risks to health. Hyris research goes beyond healthcare, as human health is connected to all nature.
We believe that transparency, accountability and sustainability are essential pillars for creating long-term value for our investors and stakeholders.
Equity Story
- Resulting from the integration of Hyris with Ulysses Biomed, enabling the merging of industrial expertise with academic research
- The Group is active in molecular diagnostics and genetic testing services at an industrial level
- Ulisse Biomed has proprietary and patented, vertically integrated technologies
- International reach: the Group operates in Europe, North America and Asia.
- Partners & projects: collaboration with clinical institutes, universities and biotech companies globally
- Ulisse Biomed S.p.A. is listed on Euronext Growth Milan
Commitment to Governance
Ulisse Biomed adopts a transparent, multilevel governance model, inspired by ESG principles and European biotech best practices. Supervision is ensured by an independent Board of Directors and technical-scientific supervisory bodies.
Communication and Transparency
All corporate documents, balance sheets, financial reports and regulated communications are available in the dedicated sections.